CAMCE(SZ:002051)2024-04-29 14:29Financial Performance - The company's operating revenue for Q1 2024 was CNY 2,362,767,576.32, a decrease of 15.27% compared to the same period last year[13]. - Net profit attributable to shareholders of the listed company was CNY 116,946,703.51, an increase of 0.67% year-on-year[13]. - The net profit after deducting non-recurring gains and losses increased by 29.97% to CNY 137,013,060.08, driven by enhanced market development and project execution[14]. - Total operating revenue for Q1 2024 was CNY 2,362,767,576.32, a decrease of 15.3% compared to CNY 2,788,678,558.20 in the previous period[21]. - Total operating costs for Q1 2024 were CNY 2,205,147,593.35, down 16.5% from CNY 2,640,293,180.41 in the previous period[21]. - The total comprehensive income for the period was 87,139,091.52, compared to 83,208,501.01 in the previous period[63]. - The total comprehensive income attributable to the parent company was 86,320,439.47, slightly down from 86,885,691.56 in the last period[63]. - Basic and diluted earnings per share remained stable at 0.09 for both periods[63]. Cash Flow - The net cash flow from operating activities decreased by 2,110.72% year-on-year, attributed to increased project payments during the reporting period[14]. - Cash inflow from operating activities was CNY 2,305,718,926.81, compared to CNY 2,693,840,116.88 in the previous period, reflecting a decrease of 14.4%[23]. - The net cash flow from operating activities was -694,901,540.63, a significant decrease compared to 34,559,878.06 in the previous period[45]. - Total cash inflow from investment activities was 25,656,588.43, down from 37,724,005.42 in the prior period[45]. - The net cash flow from investment activities was 110,721.26, a recovery from -17,151,788.15 in the previous period[45]. - Cash inflow from financing activities was 20,307,121.88, compared to 36,235,280.61 in the last period[45]. - Total cash outflow from financing activities increased to 121,974,407.71 from 48,988,828.52 in the previous period[45]. - The net cash flow from financing activities was -101,667,285.83, worsening from -12,753,547.91 in the prior period[45]. Expenses - Financial expenses decreased by 60.95% year-on-year, primarily due to exchange losses from the appreciation of the RMB in the previous year[14]. - R&D expenses increased by 98.72% year-on-year, reflecting the company's commitment to enhancing research and innovation[14]. - Research and development expenses increased to CNY 129,458,121.78, up 98.9% from CNY 65,147,166.98 in the previous period[21]. - Cash paid for purchasing goods and services was CNY 2,274,895,915.91, an increase from CNY 1,868,350,204.66 in the previous period[23]. Assets and Liabilities - Total assets at the end of the reporting period were CNY 22,632,287,012.67, a slight increase of 0.05% from the end of the previous year[13]. - The company's non-current liabilities totaled approximately 959.09 million RMB, while total liabilities reached about 11.20 billion RMB[42]. - The company’s total equity attributable to shareholders reached approximately 11.31 billion RMB, an increase from 11.22 billion RMB[42]. - The company holds a forward foreign exchange settlement amount of $193 million and €1.654 million[39]. - The company’s long-term equity investments were valued at approximately 294.83 million RMB[41]. - The company’s goodwill decreased to approximately 241.05 million RMB from 245.32 million RMB[41]. - The cash and cash equivalents at the end of the period were 6,101,007,942.12, down from 6,788,196,809.88 at the end of the previous period[45]. Shareholder Information - The company reported a total of 57,584 common shareholders at the end of the reporting period[15]. - The top three shareholders collectively hold 63.64% of the total shares, indicating potential concerted action among them[16]. Projects and Contracts - The company signed a contract for the Jiangsu Provincial People's Hospital project worth CNY 31,737,600, which includes a total construction area of 190,000 square meters[3]. - The company signed an EPC contract worth $336,580,609 for a 500,000-ton soda ash plant project in Kazakhstan, with a construction period not exceeding 1,262 days[38]. - The company has initiated the construction of the soda ash plant project, having met all conditions for commencement[38]. Miscellaneous - The company has not disclosed any new product developments or technological advancements in this report[24]. - The first quarter report has not been audited, ensuring transparency in financial disclosures[25]. - The company guarantees the accuracy and completeness of the financial information presented in the report[26].